hotspot
Previous article:
Alkermes shareholders re
Next article: Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma
Next article: Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma
focus
entertainment
-
Intellia reports positive results for its CRISPR
2025-10-02 20:06 -
With trial win, GSK could get blood cancer drug back on market
2025-10-02 20:00 -
See how much Covid
2025-10-02 19:57 -
ASCO Daily Recap: Safety data from Novartis, survival from Pfizer
2025-10-02 19:09 -
FDA's Pazdur wants cancer trials to range beyond China alone
2025-10-02 18:52 -
Letters to First Opinion on caregivers, digital health, and more
2025-10-02 18:01